TNNT2 and cancer: It therefore would be interesting to introduce measurements of cTnT or cTnI, which largely correlated in our study, into further studies, e.g., disease-specific cancer trials, and follow changes in blood concentrations over the whole chemotherapy for each patient, since a big limitation of our study with respect to the pharmacodynamic surrogates was the short trial duration for each patient.